Trial intelligence / Profile preview

Topical antibiotic-steroid drops vs oral antibiotics vs watchful waiting for acute tympanostomy tube otorrhea in children

NL-OMON26909Not yet recruiting

Sponsor
Julius Center for Health Sciences and Primary Care
Start
Feb 2009
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Randomised, open-label trial of Bacicoline-B and amoxicillin + clavulanate in tympanostomy tube otorrhea (TTO) (3 arms), sponsored by Julius Center for Health Sciences and Primary Care. Primary endpoint: Otoscopic signs of otorrhea at 2 weeks. Planned start Feb 2009; status: not yet recruiting.

02

Drugs

Bacicoline-Bamoxicillin + clavulanate
03

Conditions

tympanostomy tube otorrhea (TTO)

Beyond the preview

Go deeper on NL-OMON26909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call